Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Trenchant Capital Corp. (C:TCC)

Business Focus: Private Equity

Mar 06, 2024 09:00 am ET
Trenchant Provides Update on Corporate Developments of and Investment in GNQ Insilico Inc.
Vancouver, British Columbia--(Newsfile Corp. - March 6, 2024) - Trenchant Capital Corp. (CSE: TCC) (the "Company") announces that GNQ Insilico Inc. ("GNQ") has reported that it has commenced the development of an in silico clinical trial platform with a technology-based Fortune 100 company. On November 6, 2023, GNQ signed a Memorandum of Understanding with the Fortune 100 company to develop and commercialize an artificial intelligence (AI) driven drug development platform that integrates GNQ's genomics and epigenetic analytics, generated over 10 years through data from 15,000 case studies. The full corporate update from GNQ can be accessed here: https://www.einpresswire.com/article/693207326/gnq-insilico-announces-collaboration-with fortune-100-company-to-develop-next-generation-clinical-trial-platform.
Jan 04, 2024 09:00 am ET
Trenchant Announces Amendment to the Option Agreement and Closing of the First Tranche of Its Initial Investment in GNQ Insilico Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2024) - Trenchant Capital Corp. (CSE: TCC) (the "Company") is pleased to announce that it has entered into an amendment agreement (the "Amendment Agreement") to the previously announced option agreement between the Company and GNQ Insilico Inc. ("GNQ") dated November 30, 2023 (the "Original Option Agreement", and, together with the Amendment Agreement, the "Option Agreement"), pursuant to which the Company has closed the first tranche of its initial investment in GNQ (as defined below), such that the Company now holds approximately 5.6% of the total issued and outstanding common shares in the capital of GNQ (the "GNQ Shares").
Dec 05, 2023 12:54 pm ET
Trenchant Announces Non-Brokered Private Placement
Vancouver, British Columbia--(Newsfile Corp. - December 5, 2023) - Trenchant Capital Corp. (CSE: TCC) ("Trenchant" or the "Company") is pleased to announce that it intends to undertake a non-brokered private placement financing (the "Offering") consisting of the issuance of up to 10,000,000 units (each, a "Unit") at a price of $0.25 per Unit for gross proceeds of up to $2,500,000. Each Unit will consist of one common share (each, a "Share") and one transferable share purchase warrant (each, a "Warrant"), with each Warrant entitling the holder to purchase one additional Share at a price of $0.50 per Share for a period of two years from closing.
Dec 01, 2023 03:17 pm ET
Trenchant Announces Strategic Investment in GNQ Insilico Inc.
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2023) - Trenchant Capital Corp. (CSE: TCC) (the "Company") is pleased to announce that it has entered into a strategic investment with GNQ Insilico Inc. ("GNQ"), an Ontario-based company that is developing a generative artificial intelligence ("AI") and quantum computing platform to assist life sciences companies in conducting in silico clinical trials for drug discovery and drug development. The investment will be governed by terms of an option agreement (the "Option Agreement") entered into between GNQ and the Company, pursuant to which GNQ granted the Company the right and option (the "Option") to purchase up to 50% of the common shares in the capital of GNQ (the "GNQ Shares") during the period (the "Option Period") commencing on November 30, 2023 and ending on the earlier of November 30, 2026 or the date of a specified liquidity event involving GNQ (as set out in the Option Agreement). This is an arm's length transaction for the Company and is not subject to shareholder approval under the Policies of the Canadian Securities Exchange.
Dec 01, 2023 03:12 pm ET
Canadian Investment Regulatory Organization Trade Resumption - TCC
VANCOUVER, BC, Dec. 1, 2023 /CNW/ - Trading resumes in:
Dec 01, 2023 08:43 am ET
Canadian Investment Regulatory Organization Trading Halt - TCC
VANCOUVER, BC, Dec. 1, 2023 /CNW/ - The following issues have been halted by CIRO:
Jan 30, 2023 11:26 am ET
IIROC Trading Halt - TCC.DB.A
VANCOUVER, BC, Jan. 30, 2023 /CNW/ - The following issues have been halted by IIROC:
Jan 26, 2023 03:40 pm ET
CSE Bulletin: Maturity - Trenchant Capital Corp. 8% Series B Secured Convertible Debenture (TCC.DB.A)
Toronto, Ontario--(Newsfile Corp. - Le 26 janvier/January 2023) - Trenchant Capital Corp. 8% Series B Secured Convertible Debenture listed on August 28, 2020 will mature on January 31, 2023.
Mar 29, 2022 04:58 pm ET
CSE Bulletin: Expiry - Trenchant Capital Corp. 9% Series A Secured Convertible Debenture (TCC.DB)
Toronto, Ontario--(Newsfile Corp. - le 29 mars/March 2022) - Trenchant Capital Corp. 9% Series A Secured Convertible Debenture listed on August 28, 2020, will mature on March 31, 2022.
Apr 28, 2021 06:00 pm ET
Trenchant Capital Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - April 28, 2021) - Trenchant Capital Corp. (CSE: TCC) ("Trenchant" or the "Company") is providing an update on the status of its private equity investments following an assessment of the impact from the COVID-19 pandemic (the "Pandemic").
Aug 27, 2020 01:54 pm ET
CSE Bulletin: New Listing - Trenchant Capital Corp. (TCC, TCC.DB, TCC.DB.A)
Toronto, Ontario--(Newsfile Corp. - le 27 août/August 2020)
Aug 26, 2020 06:48 pm ET
Trenchant Announces Listing on the Canadian Securities Exchange and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2020) - Trenchant Capital Corp. (TSXV: TCC) ("Trenchant" or the "Company") announces that the Canadian Securities Exchange (the "CSE") has approved the listing of the Company's common shares, 9% Series A convertible debentures and 8% Series B convertible debentures (collectively, the "Securities") on the CSE (the "CSE Listing") and expects that the Securities will commence trading on the CSE at market open on August 28, 2020 under the symbols "TCC", "TCC.DB" and "TCC.DB.A" respectively. In connection with the CSE Listing, the Company expects to delist the Shares from the TSX Venture Exchange (the "TSXV") at the close of market on August 27, 2020.
Jun 28, 2019 03:06 pm ET
Trenchant Raises $1,761,000 in Second Tranche of 8% Convertible Debenture Offering
Trenchant Capital Corp. (TSX.V: TCC) (“Trenchant” or the “Company”) is pleased to announce that, further to its news releases dated March 19, 2019 and May 30, 2019, it has closed the second tranche of its prospectus offering (the “Debenture...
May 30, 2019 01:24 pm ET
Trenchant Raises $2,428,000 in First Tranche of 8% Convertible Debenture Offering
Trenchant Capital Corp. (TSX.V: TCC) (“Trenchant” or the “Company”) is pleased to announce that, further to its news release dated March 19, 2019, it has closed the first tranche of its prospectus offering (the “Debenture Offering”), of 8% Series B...
May 17, 2018 05:04 pm ET
Trenchant Closes Second Tranche of Prospectus Financing
Trenchant Capital Corp. (TSX.V:TCC) (“Trenchant” or the “Company”) is pleased to announce that, further to its news release dated March 26, 2018, it has closed the second tranche of its prospectus offering (the “Debenture Offering”), of 8% Series B...
Mar 26, 2018 09:00 am ET
Trenchant Closes Initial Tranche of Prospectus Financing
Also Completes Omni Initial Investment
Feb 21, 2018 12:59 pm ET
Trenchant Announces Amended Offering Terms
Toronto, Ontario--(Newsfile Corp. - February 21, 2018) - Further to its news release of January 15, 2018 and its final prospectus dated January 31, 2018, Trenchant Capital Corp. (TSXV: TCC.H) (the "Company") today announces an amendment to the terms of its proposed public offering (the "Offering") of secured convertible debentures (the "Debentures") to reduce the minimum amount of the Offering from $10 million to $5 million and to extend the initial closing date to on or about February 28, 2018. All other terms of the Offering, including the maximum Offering size of $20 million, the offering price of $1,000 per Debenture and the terms of the Debentures, remain unchanged. The minimum amount of the loan to be made by the Company (through a wholly-owned subsidiary) to ABO Investments Limited Partnership, for which the proceeds of the Offering will be used, will also be reduced from $10 million to $5 million. The Company has filed an amended and restated final prospectus with applicable securities regulators with respect to the amended offering size.
Jan 15, 2018 09:00 am ET
Trenchant Files Preliminary Prospectus for up to $20,000,000 8% Convertible Debenture Offering
Vancouver, British Columbia--(Newsfile Corp. - January 15, 2018) - Trenchant Capital Corp. (TSXV: TCC) ("Trenchant" or the "Company") is pleased to announce that it has filed and obtained a receipt for a preliminary prospectus with the securities regulatory authorities in each of the provinces of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario for a proposed public offering of a minimum of 10,000 and a maximum of 20,000 8% secured convertible debentures (the "Debentures") priced at $1,000 per Debenture (the "Offering Price"), for gross proceeds of a minimum of $10,000,000 and a maximum of $20,000,000 (the "Offering").
Dec 22, 2017 09:00 am ET
Trenchant Files Preliminary Prospectus for up to $20,000,000 8% Convertible Debenture Offering
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Trenchant Capital Corp. (TSXV: TCC) ("Trenchant" or the "Company") is pleased to announce that it has filed and obtained a receipt for a preliminary prospectus with the securities regulatory authorities in each of the provinces of British Columbia, Alberta, Saskatchewan, Manitoba and Ontario for a proposed public offering of a minimum of 10,000 and a maximum of 20,000 8% secured convertible debentures (the "Debentures") priced at $1,000 per Debenture (the "Offering Price"), for gross proceeds of a minimum of $10,000,000 and a maximum of $20,000,000 (the "Offering").
Nov 08, 2016 04:22 pm ET
IIROC Trading Resumption - CMM; SOJ; TSR.H; TCC.H
VANCOUVER, Nov. 8, 2016 /CNW/ - Trading resumes in:
Jun 07, 2016 09:34 am ET
IIROC Trading Halt - TCC.H MDN
VANCOUVER, June 7, 2016 /CNW/ - The following issues have been halted by IIROC: